Quantcast

MEDICINE AND RX

DNA Tester Sells Rights To Customers’ DNA

“This is a seminal moment for 23andMe” Jan 10, 2020 | For the first time, DNA testing company 23andMe has sold the rights to a new drug that it has developed using its customers’ data. The deal, which is being investigated as a potential treatment for inflammatory diseases, is with Spanish pharmaceutical company Almirall. “This is a seminal moment for 23andMe,” Emily Drabant Conley, 23AndMe’s vice-president of business development told Bloomberg. “We’ve now gone from database to discovery...

Deadly Fungus Now Resistant To All Known Treatments

Jan 9, 2020 Ars Technica – A deadly fungal pathogen developed the ability to resist all existing antifungal drugs on three separate occasions in the United States, according to a new report. The fungus, Candida auris, was already classified as an "urgent threat" by the Centers for Disease Control and Prevention. But the emergence of so-called "pan-resistant" strains raises additional concern, according to the report's authors, who are infectious disease specialists at the CDC and the...

New Cancer Rx: $32,000 Per Month

Jan 9, 2020 | Reuters – The U.S. Food and Drug Admin. approved Blueprint Medicines Corp’s oral therapy to treat a rare form of cancer that affects the stomach and small intestine, the agency said on Thursday. The FDA’s decision makes the therapy, Ayvakit, the first treatment for a small subset of patients with a mutation of the cancer called gastrointestinal stromal tumor (GIST). Blueprint said it expects to make Ayvakit available through a limited specialty pharmacy...

Sex Addiction, Road Rage, Temper Fits – Is It A Pill They Took?

"Soon after he began the treatment, his wife began to notice a sinister transformation ... " FDA approved meds that change who we are |  They’ve been linked to road rage, pathological gambling, and complicated acts of fraud. Some make us less neurotic, and others may even shape our social relationships. It turns out many ordinary medications don’t just affect our bodies – they affect our brains. Why? And should there be warnings on packets? Jan 8,...

Big Pharma Rings In 2020 With Price Hikes On 250 Rx

"Soaring U.S. prescription drug prices are expected to again be a central issue in the presidential election. " – REUTERS Rx price increases are well above rate of inflation Ars Technica – Leading drug makers rang in the new year by once again raising list prices of their drugs—this time on more than 250 of them, according to an analysis reported by Reuters. Data examined by healthcare research firm 3 Axis Advisors found that major drug makers...

“The Robot Will See You Now”

Doctors are being replaced by machines that do a better job and cost less  | AI beats human doctors at predicting breast cancer Jan 1, 2020 NEW SCIENTIST – An artificial intelligence system is better at predicting breast cancer than radiologists, according to a UK-US study led by Google Health. The team behind the technology hopes it can be widely deployed to improve cancer care. Detecting cancer early improves the chances of treatment succeeding. That is why many countries...

“Generic Blood Pressure Drugs Remain A Big Problem”

"The market has been plagued by shortages, often forcing people to switch their medications every couple of months."  Top 10 heart health findings of 2019 David Becker, Dec 31, 2019 Philadelphia Inquirer – There have been a number of major developments in the field of cardiology in 2019. Here is my list of the top 10 new findings that might affect your life: 1. Generic blood pressure drugs remain a big problem. When the generic drug for hypertension...
1...8910Page 10 of 10
- Advertisement -
- Advertisement -

TRENDING

- Advertisement -
- Advertisement -
- Advertisement -

RESOURCES
Subscribe to Headline Health
Not Receiving Our Emails?
Unsubscribe/Update Email
Privacy Policy
Comment Policy
Terms of Service
Material Connection Disclosure
RSS
Accessibility

CONTACT US
Advertise with Headline Health
Contact Us
Digital Millennium Copyright Act (DMCA)

HEADLINE HEALTH • PO BOX 49043 • CHARLOTTE, NC 28277

THE INFORMATION PRESENTED HERE IS FOR GENERAL EDUCATIONAL PURPOSES ONLY. YOU SHOULD ALWAYS CONSULT WITH YOUR PERSONAL PHYSICIAN REGARDING ANY PERSONAL HEALTH PROBLEM, AND YOU SHOULD ALWAYS CONSULT WITH YOUR FINANCIAL ADVISER REGARDING INVESTMENT DECISIONS. FDA DISCLOSURE: THE STATEMENTS, ARTICLES, AND PRODUCTS FEATURED IN HEADLINE HEALTH EMAILS AND AT HEADLINEHEALTH.COM HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. NO INFORMATION OR PRODUCTS APPEARING IN EMAILS OR THE WEBSITE ARE INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE. MATERIAL CONNECTION DISCLOSURE: HEADLINE HEALTH MAY HAVE AN AFFILIATE RELATIONSHIP AND/OR ANOTHER MATERIAL CONNECTION TO ANY PERSONS OR BUSINESSES MENTIONED IN OR LINKED TO FROM EMAILS OR THE WEBSITE AND MAY RECEIVE COMMISSIONS FROM PURCHASES YOU MAKE ON SUBSEQUENT WEB SITES. YOU SHOULD NOT RELY SOLELY ON INFORMATION PUBLISHED BY HEADLINE HEALTH TO EVALUATE THE PRODUCT OR SERVICE BEING OFFERED. ALWAYS EXERCISE YOUR OWN DUE DILIGENCE BEFORE PURCHASING ANY PRODUCT OR SERVICE.

Copyright 2023 HEADLINEHEALTH.COM